Evidence map›Paper›PMID 33484830›Full record

ArticleJournal of shoulder and elbow surgery2021

The critical difference in the DASH (Disabilities of the Arm, Shoulder, and Hand) outcome measure after essential upper extremity tumor surgery.

Koichi Ogura, Mohamed A Yakoub, Alexander B Christ, Tomohiro Fujiwara, Zarko Nikolic, Patrick J Boland, Edward A Athanasian, John H Healey

Abstract read
In one paragraph

Article in Journal of shoulder and elbow surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Koichi OguraDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mohamed A YakoubDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Alexander B ChristDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Tomohiro FujiwaraDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Zarko NikolicDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Patrick J BolandDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Edward A AthanasianDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
John H HealeyDepartment of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: healeyj@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

backgroundThe DASH (Disabilities of the Arm, Shoulder, and Hand) is a scored questionnaire that is widely used to evaluate the health-related quality of life of patients with upper limb musculoskeletal disorders. However, numerical changes in the measure scores lack clinical significance without meaningful threshold change values of outcome measures that are diagnostically specific. The minimal clinically important difference (MCID) is useful for the interpretation of scores by defining the smallest change that a patient would perceive. However, the MCIDs of the scores in orthopedic oncology patients has not been reported. We aimed to determine the MCIDs of the measure in orthopedic oncology patients.

methodsData from our health-related quality of life database from 1999 to 2005 were retrospectively reviewed after institutional review board approval. Seventy-eight patients who underwent surgery and completed 2 surveys during postoperative follow-up were evaluated. Two different methods were used to estimate the MCIDs: distribution-based and anchor-based approaches (the latter used receiver operating characteristic analysis).

resultsUsing distribution-based methods, the MCIDs of the DASH questionnaire were 7.4 and 8.3 by half standard deviation and the 90% interval of minimal detectable change, respectively. By anchor-based method (receiver operating characteristic analysis), the MCID was 8.3.

conclusionThe MCID values calculated by each method validates that the results for upper extremity oncology patients were similar to those reported in other orthopedic conditions. These results identify the threshold for meaningful improvements in DASH scores in orthopedic oncology patients and establish the reference to evaluate health-related quality of life and the outcomes of upper extremity oncology surgery. These data should be further refined for disease- and reconstruction-specific analyses.

Indexed as

Quality of LifeShoulderArmDisability EvaluationHumansOutcome Assessment, Health CareRetrospective StudiesSurveys and QuestionnairesUpper ExtremityDASHminimal clinically important differenceMODEMSpatient-reported outcome measuresquality of lifesarcomasurveys and questionnairesupper extremity

Identifiers

PMID33484830
PMCPMC8289920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.